Biosimilars: Strategies for AU market entry

Pearce IP’s Naomi Pearce speaks to Kate Legge about the key IP strategies to enable the launch of biosimilars around the world, with a particular focus on Australia.  Offering practical tips to success for biosimilar companies, this 14 minute PiPCast touches on:

• biosimilar FTO/clearance strategies, litigation, and settlement strategies;
• key lessons learned from the 11 AbbVie global royalty bearing deals relating to adalimumab (Humira®); and
• Australian biosimilar litigations.